The costs of litigating multimillion-dollar trade secrets and pharmaceutical cases have spiked over the past four years, even as the price of overall patent litigation has plummeted, an American Intellectual Property Law Association report shows.
The report’s data serves as a guidepost when attorneys discuss budgets with clients and is often cited in court filings when parties are looking to recover attorneys’ fees from the losing side, practitioners say.
The median cost of pharmaceutical patent cases rose 67 percent, to $2.5 million, in 2019 from 2015, according to the group’s “2019 Report of the Economic Survey.” Those cases had $1 ...